Psych Flashcards
Anorexia approved drug
NONE
Binge eating approved drug
Lisdexamphetamine (Vyvanse)
Bulimia approved drug
Fluoxetine (Prozac)
Tic disorder 1st line
alpha 2 agonists (guanfacine/clonidine)
Tic disorder 2nd line
atypical antipsychotics (aripiprazole and risperidone)
Tic disorder 3rd line
typical antipsychotic (haloperidol and pimozide)
ODD and Conduct disorder 1st line
stimulants
Pediatric age approved for ARIPIPRAZOLE
6-17 yo
Pediatric age approved for RISPERIDONE
5-16 yo
Pediatric age approved for FLUOXETINE
8 yo
Pediatric age approved for escitalopram
12 yo
Clozapine
1A2 substrate, QTc prolongation
Olanzapine
1A2 substrate, high risk of metabolic syndrome
Zyprexa Reprevv
post dose delirium syndrome can happen up to 24 hours after
Quetiapine
3A4 substrate. boxed warning for suicidal ideation
Risperidone
2D6 substrate
Risperdal Consta
weekly inj. 4 week oral supplement
Perseris
q4w subcutaneous abdominal injection. 3A4 substrate. Risperidone
Rykindo
q2w. 1 week oral supplement
Uzedy
abdominal or upper arm subcutaneous injection. Risperidone
Paliperidone
RENALLY eliminated (monitor CrCl). QTc prolongation
Invega Sustenna
load- booster-then every 4 weeks. IN DELTOID not gluteal
Invega Trinza
q3m may be given after 4 months of Sustenna
Invega Hafyra
q6m may be given after 4 months of Sustenna or after 1 dose of Trinza. GLUTEAL ONLY
Iloperidone
2D6 substrate. QTc prolongation high risk for syncope
Ziprasidone
3A4 substrate. QTc prolongation
Asenapine sublingual and patch
1A2 substrate and QTc prolongation
Lurasidone
3A4 substrate high risk for akathEsia
Pimavanserin
Parkinsons + hallucinations. INVERSE agonist. 3A4 substrate
Brexpiprazole
2D6/3A4 substrate
Aripiprazole
2D6/3A4 substrate
Cariprazine
3A4 substrate. high risk of akathesia
Lumateperone
low risk of side effects. 3A4 substrate
VMAT inhibitors
- Benazine treat tardive dyskinesia 2D6 substrate and 3A4 substrate
2D6 substrates
DECREASE dose with fluoxetine or paroxetine
1A2 substrates
INCREASE dose with cigarette smoking/ DECREASE dose with fluvoxamine
3A4 substrates
INCREASE dose with carbamazepine or phenobarbital / decrease dose with conazoles
Benzos with PTSD
NO
BENZO MOA
increases frequency of GABA channel opening. hyperpolarizes cell with increased Cl- influx
BARBITURATE MOA
increases duration of GABA channel opening. dangerous overdose!!!